Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Chronic Systolic Heart Failure (ULTIMATE-SHF)

NCT01646515 Phase 3 TERMINATED

The purpose of this study is to determine if udenafil improves exercise tolerance in patients with systolic heart failure.

Details

Lead sponsor	Seoul National University Hospital
Phase	Phase 3
Status	TERMINATED
Enrolment	41
Start date	2011-12
Completion	2014-01

Conditions

• Systolic Heart Failure

Interventions

• Placebo
• Udenafil (Zydena)

Primary outcomes

• VO2max with cardiopulmonary exercise test — Baseline and 12th weeks
  VO2 max was defined as cardiopulmonary exercise capacity Comparison between groups and within groups

Countries

South Korea